These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32217427)

  • 1. Organizing mechanism-related information on chemical interactions using a framework based on the aggregate exposure and adverse outcome pathways.
    Price PS; Jarabek AM; Burgoon LD
    Environ Int; 2020 May; 138():105673. PubMed ID: 32217427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proposal for creating a taxonomy of chemical interactions using concepts from the aggregate exposure and adverse outcome pathways.
    Price P; Leonard J
    Curr Opin Toxicol; 2019 Aug; 16():58-66. PubMed ID: 33354636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Quantitative Source-to-Outcome Case Study To Demonstrate the Integration of Human Health and Ecological End Points Using the Aggregate Exposure Pathway and Adverse Outcome Pathway Frameworks.
    Hines DE; Conolly RB; Jarabek AM
    Environ Sci Technol; 2019 Sep; 53(18):11002-11012. PubMed ID: 31436975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of gene × environment interactions on silver nanoparticle toxicity in the respiratory system: An adverse outcome pathway.
    Nicholas TP; Boyes WK; Scoville DK; Workman TW; Kavanagh TJ; Altemeier WA; Faustman EM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1708. PubMed ID: 33768701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregate Exposure Pathways in Support of Risk Assessment.
    Tan YM; Leonard JA; Edwards S; Teeguarden J; Paini A; Egeghy P
    Curr Opin Toxicol; 2018 Jun; 9():8-13. PubMed ID: 29736486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research.
    Chauhan V; Beaton D; Hamada N; Wilkins R; Burtt J; Leblanc J; Cool D; Garnier-Laplace J; Laurier D; Le Y; Yamada Y; Tollefsen KE
    Int J Radiat Biol; 2022; 98(12):1694-1703. PubMed ID: 34919011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse outcome pathway networks II: Network analytics.
    Villeneuve DL; Angrish MM; Fortin MC; Katsiadaki I; Leonard M; Margiotta-Casaluci L; Munn S; O'Brien JM; Pollesch NL; Smith LC; Zhang X; Knapen D
    Environ Toxicol Chem; 2018 Jun; 37(6):1734-1748. PubMed ID: 29492998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case Study Application of the Aggregate Exposure Pathway (AEP) and Adverse Outcome Pathway (AOP) Frameworks to Facilitate the Integration of Human Health and Ecological End Points for Cumulative Risk Assessment (CRA).
    Hines DE; Edwards SW; Conolly RB; Jarabek AM
    Environ Sci Technol; 2018 Jan; 52(2):839-849. PubMed ID: 29236470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a systematic use of effect biomarkers in population and occupational biomonitoring.
    Zare Jeddi M; Hopf NB; Viegas S; Price AB; Paini A; van Thriel C; Benfenati E; Ndaw S; Bessems J; Behnisch PA; Leng G; Duca RC; Verhagen H; Cubadda F; Brennan L; Ali I; David A; Mustieles V; Fernandez MF; Louro H; Pasanen-Kase R
    Environ Int; 2021 Jan; 146():106257. PubMed ID: 33395925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks.
    Pittman ME; Edwards SW; Ives C; Mortensen HM
    Toxicol Appl Pharmacol; 2018 Mar; 343():71-83. PubMed ID: 29454060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for the adverse outcome pathway framework to support radiation protection?
    Chauhan V; Said Z; Daka J; Sadi B; Bijlani D; Marchetti F; Beaton D; Gaw A; Li C; Burtt J; Leblanc J; Desrosiers M; Stuart M; Brossard M; Vuong NQ; Wilkins R; Qutob S; McNamee J; Wang Y; Yauk C
    Int J Radiat Biol; 2019 Feb; 95(2):225-232. PubMed ID: 30373433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Completing the Link between Exposure Science and Toxicology for Improved Environmental Health Decision Making: The Aggregate Exposure Pathway Framework.
    Teeguarden JG; Tan YM; Edwards SW; Leonard JA; Anderson KA; Corley RA; Kile ML; Simonich SM; Stone D; Tanguay RL; Waters KM; Harper SL; Williams DE
    Environ Sci Technol; 2016 May; 50(9):4579-86. PubMed ID: 26759916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AOPERA: A proposed methodology and inventory of effective tools to link chemicals to adverse outcome pathways.
    Rycroft TE; Foran CM; Thrash A; Cegan JC; Zollinger R; Linkov I; Perkins EJ; Garcia-Reyero N
    ALTEX; 2020; 37(1):64-74. PubMed ID: 31453632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Adverse Outcome Pathways Can Aid the Development and Use of Computational Prediction Models for Regulatory Toxicology.
    Wittwehr C; Aladjov H; Ankley G; Byrne HJ; de Knecht J; Heinzle E; Klambauer G; Landesmann B; Luijten M; MacKay C; Maxwell G; Meek ME; Paini A; Perkins E; Sobanski T; Villeneuve D; Waters KM; Whelan M
    Toxicol Sci; 2017 Feb; 155(2):326-336. PubMed ID: 27994170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation.
    Svingen T; Villeneuve DL; Knapen D; Panagiotou EM; Draskau MK; Damdimopoulou P; O'Brien JM
    Toxicol Sci; 2021 Nov; 184(2):183-190. PubMed ID: 34534351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Applications in Adverse Outcome Pathways and Environmental Risk Evaluation.
    Angrish MM; Allard P; McCullough SD; Druwe IL; Helbling Chadwick L; Hines E; Chorley BN
    Environ Health Perspect; 2018 Apr; 126(4):045001. PubMed ID: 29669403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: I. Challenges and research needs in ecotoxicology.
    Groh KJ; Carvalho RN; Chipman JK; Denslow ND; Halder M; Murphy CA; Roelofs D; Rolaki A; Schirmer K; Watanabe KH
    Chemosphere; 2015 Feb; 120():764-77. PubMed ID: 25439131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Data Mining Approach: Case Study with Adverse Outcome Pathway Network Leading to Pulmonary Fibrosis.
    Jeong J; Kim D; Choi J
    Chem Res Toxicol; 2023 Jun; 36(6):838-847. PubMed ID: 37093963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building and Applying Quantitative Adverse Outcome Pathway Models for Chemical Hazard and Risk Assessment.
    Perkins EJ; Ashauer R; Burgoon L; Conolly R; Landesmann B; Mackay C; Murphy CA; Pollesch N; Wheeler JR; Zupanic A; Scholz S
    Environ Toxicol Chem; 2019 Sep; 38(9):1850-1865. PubMed ID: 31127958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The integration of the adverse outcome pathway framework to radiation risk assessment.
    Chauhan V; Stricklin D; Cool D
    Int J Radiat Biol; 2021; 97(1):60-67. PubMed ID: 32397918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.